Hurco Companies, Inc. Announces Quarterly Cash Dividend
Mar 10, 2016 13:00 pm UTC| Business
INDIANAPOLIS, March 10, 2016 -- Hurco Companies, Inc. (Nasdaq:HURC), an international industrial technology company, announced today that its Board of Directors approved the payment of a cash dividend of $0.09 per...
Depomed to Host Analyst and Investor Day on Wednesday, March 23
Mar 10, 2016 13:00 pm UTC| Business
NEWARK, Calif., March 10, 2016 -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will host an Analyst and Investor Day on Wednesday, March 23, 2016. The details are as follows: Date: Wednesday, March 23, 2016Time:...
Voyager Therapeutics to Host Fourth Quarter and Full Year 2015 Investor Update Call
Mar 10, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., March 10, 2016 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), today...
Mar 10, 2016 13:00 pm UTC| Business
LOS ANGELES, March 10, 2016 -- Johnson Weaver, LLP announces that the United States District Court for the Central District of California has approved the following announcement of a proposed class action settlement...
MGP Ingredients Board Declares $0.08 Annual Dividend
Mar 10, 2016 12:50 pm UTC| Business
ATCHISON, Kan., March 10, 2016 -- MGPIngredients, Inc. (Nasdaq:MGPI), a leading supplier of premium distilled spirits and specialty wheat proteins and starches, today announced that its board of directors has declared...
Mar 10, 2016 12:42 pm UTC| Business
Dublin, March 10, 2016 -- Research and Markets has announced the addition of the RFID in Healthcare Market report to their offering. This comprehensive report analyzes the global RFID in healthcare market and the...
Matinas BioPharma to Present at the 28th Annual ROTH Conference
Mar 10, 2016 12:35 pm UTC| Business
BEDMINSTER, N.J., March 10, 2016 -- Matinas BioPharma Holdings, Inc. (OTCQB:MTNB), a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective therapeutics for the treatment of...